Peter D. Haytaian - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP & Pres Carelon & CarelonRx
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 16:57:53 UTC
Previous filing
05 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Haytaian Peter D EVP & Pres Carelon & CarelonRx 220 VIRGINIA AVENUE, INDIANAPOLIS /s/ Kathleen S. Kiefer, Attorney in fact 04 Mar 2026 0001608538

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -1,201 -4.6% $294.07* 24,803 02 Mar 2026 Direct F1
transaction ELV Common Stock Award +2,865 +12% $0.000000* 27,668 02 Mar 2026 Direct F2
transaction ELV Common Stock Tax liability -446 -1.6% $284.03* 27,222 03 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.